Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NFLX vs MRNA✓SelectedUSD · MRNANFLX vs MRNA performance historyLatest closeAs of+0.23%11/18
Stock and ETF performance explorer

NFLX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-11.9%
MRNA return
-25.9%
Excess return
+14.0%
Maximum drawdown
-75.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.2%-4.8%+5.1%+0.5%
7D-7.3%-20.9%+13.6%-6.0%
30D-14.4%-13.3%-1.1%-13.8%
3M-23.1%+212.6%-235.6%-32.4%
6M-33.3%+309.0%-342.3%-43.9%
YTD-36.2%+567.3%-603.5%-50.7%
1Y-47.6%+689.7%-737.3%-60.7%
3Y+28.4%+157.4%-129.0%+6.1%
All-11.9%-25.9%+14.0%-15.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling